4.6 Article

Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen

Journal

PLOS BIOLOGY
Volume 19, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pbio.3001115

Keywords

-

Funding

  1. Medical Research Council [MC_UU_1201412]
  2. Wellcome Trust [220977/Z/20/Z, 206369/Z/17/Z, 206298/Z/17/Z]
  3. National Institutes of Health [R01 AI134384]
  4. National Science Foundation [2027196]
  5. European Research Council under the European Union's Horizon 2020 research and innovation programme [725422]
  6. European Union's Horizon 2020 project MOOD [874850]
  7. Research Foundation -Flanders ('Fonds voor Wetenschappelijk Onderzoek -Vlaanderen') [G066215N, G0D5117N, G0B9317N]
  8. Bill and Melinda Gates Foundation [INV-005517]
  9. NIH/NIAID Center of Excellence in Influenza Research and Surveillance [HHS N272201400007C]
  10. Wellcome Trust [220977/Z/20/Z, 206369/Z/17/Z] Funding Source: Wellcome Trust
  11. Direct For Biological Sciences
  12. Div Of Biological Infrastructure [2027196] Funding Source: National Science Foundation
  13. Bill and Melinda Gates Foundation [INV-005517] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

The study suggests that SARS-CoV-2 has undergone limited significant adaptation to humans, with evidence of moderate positive selection concentrated in the early phases of the pandemic. In contrast, bat Sarbecoviruses show evidence of significant positive selection and an adaptive depletion in CpG composition. This indicates that the progenitor of SARS-CoV-2 likely acquired efficient human-human transmission capabilities through evolutionary history in bats, leading to the emergence of a relatively generalist virus.
Virus host shifts are generally associated with novel adaptations to exploit the cells of the new host species optimally. Surprisingly, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has apparently required little to no significant adaptation to humans since the start of the Coronavirus Disease 2019 (COVID-19) pandemic and to October 2020. Here we assess the types of natural selection taking place in Sarbecoviruses in horseshoe bats versus the early SARS-CoV-2 evolution in humans. While there is moderate evidence of diversifying positive selection in SARS-CoV-2 in humans, it is limited to the early phase of the pandemic, and purifying selection is much weaker in SARS-CoV-2 than in related bat Sarbecoviruses. In contrast, our analysis detects evidence for significant positive episodic diversifying selection acting at the base of the bat virus lineage SARS-CoV-2 emerged from, accompanied by an adaptive depletion in CpG composition presumed to be linked to the action of antiviral mechanisms in these ancestral bat hosts. The closest bat virus to SARS-CoV-2, RmYN02 (sharing an ancestor about 1976), is a recombinant with a structure that includes differential CpG content in Spike; clear evidence of coinfection and evolution in bats without involvement of other species. While an undiscovered facilitating intermediate species cannot be discounted, collectively, our results support the progenitor of SARS-CoV-2 being capable of efficient human-human transmission as a consequence of its adaptive evolutionary history in bats, not humans, which created a relatively generalist virus.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available